Q&A with Dr. Matthias von Herrath
When Novo Nordisk, a global pharmaceutical company headquartered in Denmark and best known for its diabetes products, wanted to reinvigorate
When Novo Nordisk, a global pharmaceutical company headquartered in Denmark and best known for its diabetes products, wanted to reinvigorate
Turnstone Planning to Initiate Phase I/II Clinical Trial Utilizing Personalized Neoantigen Therapy with Proprietary MG1 Viral Platform in 2019 NEW
LA JOLLA, CA—Neutrophils—short-lived, highly mobile and versatile—outnumber all other immune cells circulating through the blood stream. Yet, despite the cells’
When research intern Hope Steele joined mentor Rana Herro, Ph.D., for nine weeks to gain some hands-on-experience in a lab,
LA JOLLA, CA—The National Institute of General Medical Sciences (NIGMS) has awarded La Jolla Institute’s Ferhat Ay, Ph.D., $ 2.24
LA JOLLA, CA—An army of diverse immune cells guards the lining of your intestine against invasion by bacterial pathogens. Once
LA JOLLA, CA—Dengue and Zika viruses are closely related and carried by mosquitos. In infested subtropical and tropical areas, dengue
LA JOLLA, CA—Dr. Kimishige Ishizaka, discoverer of a novel class of antibodies and the first Scientific Director of the La
LA JOLLA, CA— The current whooping cough vaccine was universally adopted in the US in 1996 to replace the original
LA JOLLA, CA— Allergic asthma is a chronic inflammatory disease of the lung and airways driven, at least in part,
LA JOLLA, CA – A global health leader, the head of research and development for an international specialty pharmaceutical company
LA JOLLA, CA – The La Jolla Institute for Immunology is pleased to announce that Mitsuo Satoh, Ph.D., executive officer,